Access to Innovation
Requires Subscription or Fee PDF

Keywords

Innovation
Access
Adherence
Outcomes
Patient-Centric Care
Responsibility
Investment
Regulatory Science
QALY
Value-Based Insurance Design

Abstract

Healthcare innovation saves lives, saves money, promotes economic growth, and provides hope for hundreds of millions of people (both patients and care-givers) in the United States and around the world. But innovation isn’t easy.

There are many roadblocks beyond those of discovery and development. The complicated and conflicting dynamics of politics, perspectives on healthcare economics, of friction between payers, providers, manufacturers, and regulators, the battle for better patient education, and the need for a more forceful and factual debate over the value of innovation all create the need for a more balanced and robust debate.

Should we blame our skewed priorities? American healthcare often works miracles when people become very ill, but it needs to do a better job with preventive care. Equally to blame is the fact that we spend a disproportionate amount of our healthcare budget for end-of-life care.

Rather than tangle up the already volatile healthcare debate in ethical arguments over whose life is worth more, it would be smarter to shift the focus to keeping people healthier longer. Earlier diagnosis and care are crucial to the future health of both Americans and American healthcare—and pharma has a starring role here.

We cannot afford, in terms of dollars or lives, to continue the blame game. In order to deliver on the promise of affordable and quality healthcare for all citizens, all the players in the healthcare debate must work together. At the end of the day, we should unite against our common enemy—disease.

And our most potent weapon in innovation.

https://doi.org/10.5912/jcb684
Requires Subscription or Fee PDF

References

http://visualeconomics.creditloan.com/100-years-of-consumer-spending/

http://economistsview.typepad.com/economistsview/2007/11/mankiw-beyond-t.html

http://www.nytimes.com/2010/08/19/health/19alzheimers.html?_r=0

http://www.innovation.org/index.cfm/insidedrugdiscovery

http://csdd.tufts.edu/

http://www.washingtontimes.com/news/2008/may/12/health-care-realities/

Ibid

http://www.econ.yale.edu/~nordhaus/.../health_nber_1.doc

http://www.ashpmedia.org/AJHP/DrugExpenditures-2014.pdf

http://www.nytimes.com/2014/07/24/business/sales-of-hepatitis-c-drug-sovaldi-soar.html

http://www.reuters.com/article/2014/05/28/us-usa-healthcare-hepatitisc-insight-idUSKBN0E80AZ20140528

http://www.drugs.com/clinical_trials/pegasys-proven-effective-hepatitis-c-latino-patients-according-article-new-england-journal-medicine-6620.html

http://www.healio.com/gastroenterology/curbside-consultation/%7Ba8b9ec89-2c79-4696-a702-84e9fad15233%7D/what-is-the-likelihood-t

http://www.focr.org/news/inside-health-policy-fda-drug-chief-drug-cures-progress-could-require-down-payment

http://www.pwc.com/us/en/health-industries/behind-the-numbers/specialty-drugs.jhtml

http://thomas.loc.gov/cgi-bin/query/z?c111:H.R.3200:

http://www.sph.umich.edu/vbidcenter/registry/pdfs/NPC_VBIDreport_7-22-09.pdf

http://www.stockholm-network.org/downloads/events/Lichtenberg.pdf

http://fortune.com/?s=why-were-losing-the-war-on-cancer%2F

http://www.nejm.org/doi/full/10.1056/NEJM199705293362206

http://www.researchgate.net/publication/46555895_Are_Increasing_5-Year_Survival_Rates_Evidence_of_Success_Against_Cancer_A_Reexamination_Using_Data_from_the_U.S._and_Australia/file/e0b49521388f04d272.pdf

Hartung DM, Ketchum KL, Haxby DG. An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug Plan.Health Affairs 2006;25:1423-32.

http://www.wolterskluwerhealth.com/News/Pages/Symposium-Focuses-on-Disparities-in-Cardiovascular-Disease.aspx

http://www.healthpocket.com/healthcare-research/infostat/prescription-drug-coverage-and-affordable-care-act#.U_sp9UgQGiw

http://www.csro.info/

http://www.bemedicinesmart.org/Medication_Adherence_Fact%20Sheet.pdf

http://www.burrillreport.com/printer_article-facing_an_adherence_and_compliance_gap.html

http://www.adherenthealth.com/whatsnew/index.php

https://www.linkedin.com/pulse/article/20140612143605-322581966-why-society-needs-a-vibrant-pharmaceutical-industry-improving-patients-lives

http://www.innovation.org/index.cfm/insidedrugdiscovery

http://www.cms.gov/CCIIO/Programs-and-Initiatives/Health-Insurance-Market-Reforms/Review-of-Insurance-Rates.html

http://www.cdc.gov/nchs/data/nhsr/nhsr007.pdf

http://www.ibiweb.org/community-events/detail/more-evidence-that-improving-health-can-improve-productivity

Unless specified by prior arrangement, the author agrees to the following terms and assurances:

  1. For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
  2. I/we further give to the following assurances
    1. I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
    2. I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
    3. To the best of my/our knowledge, all the facts in the contribution are true and accurate;
    4. The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
    5. Nothing in the contribution is obscene or libellous;
    6. Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
    7. I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).
* Works by US government employees prepared as part of official duties are in the public domain and the authors are therefore exempt from copyright assignment.